SCHEMBL3635482

SCHEMBL3635482

O=C(Oc1ccccc1O)c1ccccc1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.76
HSD17B10 Q99714 6/20 0.76
ALDH1A1 P00352 5/20 0.76
KDM4E B2RXH2 5/20 0.76
KMT2A Q03164 4/20 0.69
GAA P10253 3/20 0.69
POLB P06746 1/20 0.69
ALOX15 P16050 2/20 0.66
LMNA P02545 4/20 0.59
TSHR P16473 2/20 0.59
TDP1 Q9NUW8 2/20 0.58
ESR1 P03372 4/20 0.54
ESR2 Q92731 4/20 0.54
MEN1 O00255 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10686808 0.88 HSD17B10 (0.71) HPGDHSD17B10ALDH1A1KDM4EKMT2A
Salsalate SCHEMBL2025628 0.86 HSD17B10 (1.00) HPGDHSD17B10ALDH1A1KDM4EKMT2A
Salsalate SCHEMBL29362887 0.86 HSD17B10 (1.00) HPGDHSD17B10ALDH1A1KDM4EKMT2A
SCHEMBL7038760 0.86 HSD17B10 (0.74) HPGDHSD17B10ALDH1A1KDM4EKMT2A
Salsalate SCHEMBL15562 0.86 HSD17B10 (1.00) HPGDHSD17B10ALDH1A1KDM4EKMT2A
SCHEMBL10786871 0.86 KMT2A (0.68) HPGDHSD17B10ALDH1A1KDM4EKMT2A
SCHEMBL28994312 0.85 KMT2A (0.61) HPGDHSD17B10ALDH1A1KDM4EKMT2A
Salsalate SCHEMBL25260636 0.85 HSD17B10 (0.96) HPGDHSD17B10ALDH1A1KDM4EKMT2A
SCHEMBL13826872 0.85 HSD17B10 (0.96) HPGDHSD17B10ALDH1A1KDM4EKMT2A
Salsalate SCHEMBL9624915 0.85 HSD17B10 (0.96) HPGDHSD17B10ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8313799-B2 Adhesive detection methods HENKEL CORPORATION (US) 2012-11-20 US claimed
US-20100304008-A1 ADHESIVE DETECTION METHODS Henkel IP & Holding GmbH (DE) 2010-12-02 US claimed
EP-2150596-A2 ADHESIVE DETECTION METHODS Henkel Corporation (US) 2010-02-10 EP claimed
WO-2008153659-A2 ADHESIVE DETECTION METHODS HENKEL CORPORATION (US) 2008-12-18 WO claimed
EP-0661591-B1 Photographic elements containing loaded ultraviolet absorbing polymer latex EASTMAN KODAK CO (US) 2000-10-04 EP claimed
EP-2582709-B1 AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES SANOFI SA (FR) 2018-01-24 EP disclosed
EP-2188273-B1 SUBSTITUTED TETRA HYDRO NAPHTHALINES, METHOD FOR THEIR MANUFACTURE AND THEIR USE AS DRUGS SANOFI SA (FR) 2014-10-22 EP disclosed
US-20140088077-A1 NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS SANOFI (FR) 2014-03-27 US disclosed
US-20140088077-A1 NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS SANOFI (FR) 2014-03-27 US disclosed
EP-2220040-B1 NEW CRYSTALLINE DIPHENYL ACETIDINONE HYDRATE, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUND AND USE THEREOF SANOFI AVENTIS DEUTSCHLAND (DE) 2013-01-16 EP disclosed
US-8313799-B2 Adhesive detection methods HENKEL CORPORATION (US) 2012-11-20 US disclosed
WO-2011157827-A1 AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES SANOFI (FR) 2011-12-22 WO disclosed
JP-2000212131-A NEW (METH)ACRYLATE-BASED COMPOUND AND DENTAL POLYMERIZABLE COMPOSITION CONTAINING THE COMPOUND KURARAY CO LTD 2000-08-02 JP disclosed
EP-0989963-A1 RADIATION-CURABLE OPTICAL FIBER COATINGS HAVING REDUCED YELLOWING AND FAST CURE SPEED DSM N.V. (NL) 2000-04-05 EP disclosed
US-5932353-A NYLON AND POLYURETHANE BLENDS BASF CORPORATION (US) 1999-08-03 US disclosed
WO-1999034248-A1 COMPOSITE HOLOGRAPHIC MULTIFOCAL LENS NOVARTIS AG (CH) 1999-07-08 WO disclosed
WO-1998057902-A1 RADIATION-CURABLE OPTICAL FIBER COATINGS HAVING REDUCED YELLOWING AND FAST CURE SPEED DSM N.V. (NL) 1998-12-23 WO disclosed
US-5785916-A MOLDING POLYURETHANE MATRIX CONTAINING DISPERSED ACRYLIC RUBBER PARTICLES, BENZOTRIAZOLE ULTRAVIOLET STABILIZERS AND PHENOLIC HEAT STABILIZERS, ELASTICITY, HARDNESS BASF CORPORATION (US) 1998-07-28 US disclosed
EP-0769527-A1 Thermoplastic polyurethane compositions exhibiting improved UV and heat resistance BASF CORPORATION (US) 1997-04-23 EP disclosed
US-5286703-A Having color developing layer and ultraviolet absorbing layer with specific light transmittance; lightfastness FUJI PHOTO FILM CO., LTD. (JP) 1994-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088077-A1 NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS DHPS, CYP11B2, CYP11B1 HPGD 134/4885HSD17B10 587/4885ALDH1A1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.